Cost of care for cancer patients in England

evidence from population-based patient-level data

Mauro Laudicella*, Brendan Walsh, Elaine Burns, Peter C Smith

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Resumé

BACKGROUND: Health systems are facing the challenge of providing care to an increasing population of patients with cancer. However, evidence on costs is limited due to the lack of large longitudinal databases.

METHODS: We matched cost of care data to population-based, patient-level data on cancer patients in England. We conducted a retrospective cohort study including all patients age 18 and over with a diagnosis of colorectal (275 985 patients), breast (359 771), prostate (286 426) and lung cancer (283 940) in England between 2001 and 2010. Incidence costs, prevalence costs, and phase of care costs were estimated separately for patients age 18-64 and ⩾65. Costs of care were compared by patients staging, before and after diagnosis, and with a comparison population without cancer.

RESULTS: Incidence costs in the first year of diagnosis are noticeably higher in patients age 18-64 than age ⩾65 across all examined cancers. A lower stage diagnosis is associated with larger cost savings for colorectal and breast cancer in both age groups. The additional costs of care because of the main four cancers amounts to £1.5 billion in 2010, namely 3.0% of the total cost of hospital care.

CONCLUSIONS: Population-based, patient-level data can be used to provide new evidence on the cost of cancer in England. Early diagnosis and cancer prevention have scope for achieving large cost savings for the health system.

OriginalsprogEngelsk
TidsskriftBritish Journal of Cancer
Vol/bind114
Udgave nummer11
Sider (fra-til)1286-92
ISSN0007-0920
DOI
StatusUdgivet - 24. maj 2016
Udgivet eksterntJa

Fingeraftryk

England
Population
Neoplasms
Cost Savings
Hospital Costs
Incidence
Health
Early Detection of Cancer
Colorectal Neoplasms
Prostatic Neoplasms
Cohort Studies
Retrospective Studies
Age Groups
Databases

Citer dette

Laudicella, Mauro ; Walsh, Brendan ; Burns, Elaine ; Smith, Peter C. / Cost of care for cancer patients in England : evidence from population-based patient-level data. I: British Journal of Cancer. 2016 ; Bind 114, Nr. 11. s. 1286-92.
@article{a38eda8198e44cea9d53801541a1ccc5,
title = "Cost of care for cancer patients in England: evidence from population-based patient-level data",
abstract = "BACKGROUND: Health systems are facing the challenge of providing care to an increasing population of patients with cancer. However, evidence on costs is limited due to the lack of large longitudinal databases.METHODS: We matched cost of care data to population-based, patient-level data on cancer patients in England. We conducted a retrospective cohort study including all patients age 18 and over with a diagnosis of colorectal (275 985 patients), breast (359 771), prostate (286 426) and lung cancer (283 940) in England between 2001 and 2010. Incidence costs, prevalence costs, and phase of care costs were estimated separately for patients age 18-64 and ⩾65. Costs of care were compared by patients staging, before and after diagnosis, and with a comparison population without cancer.RESULTS: Incidence costs in the first year of diagnosis are noticeably higher in patients age 18-64 than age ⩾65 across all examined cancers. A lower stage diagnosis is associated with larger cost savings for colorectal and breast cancer in both age groups. The additional costs of care because of the main four cancers amounts to £1.5 billion in 2010, namely 3.0{\%} of the total cost of hospital care.CONCLUSIONS: Population-based, patient-level data can be used to provide new evidence on the cost of cancer in England. Early diagnosis and cancer prevention have scope for achieving large cost savings for the health system.",
keywords = "Adolescent, Adult, Aged, Aged, 80 and over, England/epidemiology, Female, Health Care Costs/statistics & numerical data, Humans, Incidence, Male, Middle Aged, Neoplasms/economics, Prevalence, Retrospective Studies, State Medicine/economics, Young Adult",
author = "Mauro Laudicella and Brendan Walsh and Elaine Burns and Smith, {Peter C}",
year = "2016",
month = "5",
day = "24",
doi = "10.1038/bjc.2016.77",
language = "English",
volume = "114",
pages = "1286--92",
journal = "B J C",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "11",

}

Cost of care for cancer patients in England : evidence from population-based patient-level data. / Laudicella, Mauro; Walsh, Brendan; Burns, Elaine; Smith, Peter C.

I: British Journal of Cancer, Bind 114, Nr. 11, 24.05.2016, s. 1286-92.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Cost of care for cancer patients in England

T2 - evidence from population-based patient-level data

AU - Laudicella, Mauro

AU - Walsh, Brendan

AU - Burns, Elaine

AU - Smith, Peter C

PY - 2016/5/24

Y1 - 2016/5/24

N2 - BACKGROUND: Health systems are facing the challenge of providing care to an increasing population of patients with cancer. However, evidence on costs is limited due to the lack of large longitudinal databases.METHODS: We matched cost of care data to population-based, patient-level data on cancer patients in England. We conducted a retrospective cohort study including all patients age 18 and over with a diagnosis of colorectal (275 985 patients), breast (359 771), prostate (286 426) and lung cancer (283 940) in England between 2001 and 2010. Incidence costs, prevalence costs, and phase of care costs were estimated separately for patients age 18-64 and ⩾65. Costs of care were compared by patients staging, before and after diagnosis, and with a comparison population without cancer.RESULTS: Incidence costs in the first year of diagnosis are noticeably higher in patients age 18-64 than age ⩾65 across all examined cancers. A lower stage diagnosis is associated with larger cost savings for colorectal and breast cancer in both age groups. The additional costs of care because of the main four cancers amounts to £1.5 billion in 2010, namely 3.0% of the total cost of hospital care.CONCLUSIONS: Population-based, patient-level data can be used to provide new evidence on the cost of cancer in England. Early diagnosis and cancer prevention have scope for achieving large cost savings for the health system.

AB - BACKGROUND: Health systems are facing the challenge of providing care to an increasing population of patients with cancer. However, evidence on costs is limited due to the lack of large longitudinal databases.METHODS: We matched cost of care data to population-based, patient-level data on cancer patients in England. We conducted a retrospective cohort study including all patients age 18 and over with a diagnosis of colorectal (275 985 patients), breast (359 771), prostate (286 426) and lung cancer (283 940) in England between 2001 and 2010. Incidence costs, prevalence costs, and phase of care costs were estimated separately for patients age 18-64 and ⩾65. Costs of care were compared by patients staging, before and after diagnosis, and with a comparison population without cancer.RESULTS: Incidence costs in the first year of diagnosis are noticeably higher in patients age 18-64 than age ⩾65 across all examined cancers. A lower stage diagnosis is associated with larger cost savings for colorectal and breast cancer in both age groups. The additional costs of care because of the main four cancers amounts to £1.5 billion in 2010, namely 3.0% of the total cost of hospital care.CONCLUSIONS: Population-based, patient-level data can be used to provide new evidence on the cost of cancer in England. Early diagnosis and cancer prevention have scope for achieving large cost savings for the health system.

KW - Adolescent

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - England/epidemiology

KW - Female

KW - Health Care Costs/statistics & numerical data

KW - Humans

KW - Incidence

KW - Male

KW - Middle Aged

KW - Neoplasms/economics

KW - Prevalence

KW - Retrospective Studies

KW - State Medicine/economics

KW - Young Adult

U2 - 10.1038/bjc.2016.77

DO - 10.1038/bjc.2016.77

M3 - Journal article

VL - 114

SP - 1286

EP - 1292

JO - B J C

JF - B J C

SN - 0007-0920

IS - 11

ER -